{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:46:48Z","timestamp":1781945208785,"version":"3.54.5"},"reference-count":38,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"5x1000 anno 2020\u2013Deliberazione n.655\/2022"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Cancer-associated thrombosis is the second leading cause of death in cancer patients, and its incidence has been increasing in recent years. This survey was aimed at gathering information regarding the management of thromboembolic prophylaxis within the MITO (Multicenter Italian Trials in Ovarian Cancer)-MaNGO (Mario Negri Gynecologic Oncology) groups. We designed a self-administered, multiple-choice online questionnaire available only for MITO-MaNGO members for one month, starting in May 2022 and ending in June 2022. We processed one response form per center, and 50 responses were analyzed, with most of the respondents (78%) over 40 years old. We found that 82% of them consider thromboembolic prophylaxis in gynecologic oncology to be relevant. In 82% of the centers, a standardized protocol on venous thromboembolism (VTE) prophylaxis is used, which is applied to both patients undergoing surgery and those undergoing chemotherapy. In the remaining 18% of centers, prophylaxis is used exclusively for patients undergoing chemotherapy treatment. Prophylaxis of patients undergoing surgery and chemotherapy treatment is managed in most cases by the surgeon (72%) and oncologist (76%), respectively. Only 26% of respondents use a thromboembolic risk assessment scale, and of these, those used are the Caprini Score (6%), Khorana Score (6%), and Wells Score (2%). The respondents have good knowledge of low-molecular-weight heparin (90%) and average knowledge of dicumarolics (40%), direct oral anticoagulants (DOACs) (68%), and antiplatelet agents (40%). The results of our survey indicate that there is a good awareness of thromboembolic prophylaxis in gynecologic oncology. Nevertheless, it is used less in outpatients than in patients undergoing surgery. Moreover, the thromboembolic risk assessment scores are barely used.<\/jats:p>","DOI":"10.3390\/diagnostics14111159","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T06:35:32Z","timestamp":1717137332000},"page":"1159","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Venous Thromboembolism Prophylaxis in Gynecologic Oncology: A MITO-MaNGO Survey"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2483-4451","authenticated-orcid":false,"given":"Michele","family":"Mongelli","sequence":"first","affiliation":[{"name":"Obstetrics and Gynecology Unit, University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica","family":"Lorusso","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico IRCCS, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanna","family":"Zanagnolo","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Istituto Europeo di Oncologia, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8836-2633","authenticated-orcid":false,"given":"Sandro","family":"Pignata","sequence":"additional","affiliation":[{"name":"Department of Urology and Gynecology, Istituto Nazionale Tumori, Istituto di Ricovero e Cura a Carattere Scientifico IRCCS, Fondazione G. Pascale, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Colombo","sequence":"additional","affiliation":[{"name":"Gynecologic Oncology Program, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico IRCCS, 20139 Milan, Italy"},{"name":"School of Medicine and Surgery, University of Milan-Bicocca, 20126 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5745-372X","authenticated-orcid":false,"given":"Gennaro","family":"Cormio","sequence":"additional","affiliation":[{"name":"S.S.D. Ginecologia Oncologica Clinicizzata, IRCCS Istituto Tumori \u201cGiovanni Paolo II\u201d, 70124 Bari, Italy"},{"name":"Department of Interdisciplinary Medicine (DIM), University of Bari \u201cAldo Moro\u201d, 70124 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","article-title":"Epidemiology and prevention of venous thromboembolism","volume":"20","author":"Lutsey","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.21037\/cdt.2017.09.01","article-title":"Deep vein thrombosis: Pathogenesis, diagnosis, and medical management","volume":"7","author":"Stone","year":"2017","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e072715","DOI":"10.1136\/bmj-2022-072715","article-title":"Prevention of venous thromboembolism in patients with cancer","volume":"381","author":"Guntupalli","year":"2023","journal-title":"BMJ"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hohaus, S., Bartolomei, F., Cuccaro, A., Maiolo, E., Alma, E., D\u2019Al\u00f2, F., Bellesi, S., Rossi, E., and Stefano, V.D. (2020). Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis. Cancers, 12.","DOI":"10.3390\/cancers12051291"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1097\/IGC.0000000000001111","article-title":"Venous Thromboembolism in Gynecological Malignancy","volume":"27","author":"Cohen","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"445.e1","DOI":"10.1016\/j.ajog.2016.04.034","article-title":"The limited utility of currently available venous thromboembolism risk assessment tools in gynecological oncology patients","volume":"215","author":"Barber","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.thromres.2013.01.027","article-title":"Incidence of venous thromboembolism before treatment in cervical cancer and the impact of management on venous thromboembolism after commencement of treatment","volume":"131","author":"Satoh","year":"2013","journal-title":"Thromb. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1097\/AOG.0000000000000866","article-title":"Incidence and Effects on Mortality of Venous Thromboembolism in Elderly Women with Endometrial Cancer","volume":"125","author":"Hariton","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ygyno.2014.04.046","article-title":"The survival detriment of venous thromboembolism with epithelial ovarian cancer","volume":"134","author":"Gunderson","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s13643-021-01814-2","article-title":"Systematic reviews of observational studies of Risk of Thrombosis and Bleeding in General and Gynecologic Surgery (ROTBIGGS): Introduction and methodology","volume":"10","author":"Lavikainen","year":"2021","journal-title":"Syst. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e000188","DOI":"10.1136\/esmoopen-2017-000188","article-title":"Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: Review of the literature on current practice and emerging options","volume":"2","author":"Ay","year":"2017","journal-title":"ESMO Open"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1378\/chest.10-1944","article-title":"Predictive and Associative Models to Identify Hospitalized Medical Patients at Risk for VTE","volume":"140","author":"Spyropoulos","year":"2011","journal-title":"Chest"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.amjmed.2015.10.027","article-title":"Assessing the Caprini Score for Risk Assessment of Venous Thromboembolism in Hospitalized Medical Patients","volume":"129","author":"Grant","year":"2016","journal-title":"Am. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1001.e9","DOI":"10.1016\/j.amjmed.2016.03.031","article-title":"Validation of Risk Assessment Models of Venous Thromboembolism in Hospitalized Medical Patients","volume":"129","author":"Greene","year":"2016","journal-title":"Am. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e045672","DOI":"10.1136\/bmjopen-2020-045672","article-title":"Risk assessment models for venous thromboembolism in hospitalised adult patients: A systematic review","volume":"11","author":"Pandor","year":"2021","journal-title":"BMJ Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.thromres.2018.02.004","article-title":"Updated clinical models for VTE prediction in hospitalized medical patients","volume":"164","author":"Gerotziafas","year":"2018","journal-title":"Thromb. Res."},{"key":"ref_17","first-page":"1181","article-title":"Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"15","author":"Streiff","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","article-title":"Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline","volume":"34","author":"Falanga","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e002267","DOI":"10.1136\/bmjoq-2023-002267","article-title":"Effectiveness of an artificial intelligence clinical assistant decision support system to improve the incidence of hospital-associated venous thromboembolism: A prospective, randomised controlled study","volume":"12","author":"Huang","year":"2023","journal-title":"BMJ Open Qual."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/S2352-3026(18)30111-X","article-title":"Artificial intelligence for cancer-associated thrombosis risk assessment","volume":"5","author":"Ferroni","year":"2018","journal-title":"Lancet Haematol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"(2021). Prevention of Venous Thromboembolism in Gynecologic Surgery: ACOG Practice Bulletin Summary, Number 232. Obstet. Gynecol., 138, 158\u2013161.","DOI":"10.1097\/AOG.0000000000004446"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Romano, F., Di Lorenzo, G., Stabile, G., Mirandola, M., Restaino, S., Ianniello, P., Mirenda, G., and Ricci, G. (2022). A Systematic Review of the Guidelines on Venous Thromboembolism Prophylaxis in Gynecologic Oncology. Cancers, 14.","DOI":"10.3390\/cancers14102439"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ygyno.2020.11.020","article-title":"Direct oral anticoagulant use in gynecologic oncology: A Society of Gynecologic Oncology Clinical Practice Statement","volume":"160","author":"Gressel","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2021.06.021","article-title":"Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism\u2014The COSIMO study","volume":"206","author":"Cohen","year":"2021","journal-title":"Thromb. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e207410","DOI":"10.1001\/jamanetworkopen.2020.7410","article-title":"Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical Trial","volume":"3","author":"Guntupalli","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"20371","DOI":"10.18632\/oncotarget.13620","article-title":"Efficacy of intermittent pneumatic compression for venous thromboembolism prophylaxis in patients undergoing gynecologic surgery: A systematic review and meta-analysis","volume":"8","author":"Feng","year":"2017","journal-title":"Oncotarget"},{"key":"ref_27","unstructured":"The Cochrane Collaboration (2000). Cochrane Database of Systematic Reviews, John Wiley & Sons, Ltd."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1055\/s-0040-1718927","article-title":"Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: Risk Factors and Prevention","volume":"47","author":"Prandoni","year":"2021","journal-title":"Semin. Thromb Hemost."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.ejca.2015.07.012","article-title":"Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma","volume":"51","author":"Matsuo","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.jogc.2021.05.010","article-title":"Venous Thromboembolism in Patients Receiving Neoadjuvant Chemotherapy for Advanced Ovarian Cancer and Impact on Survival","volume":"43","author":"Black","year":"2021","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2374716","DOI":"10.1155\/2020\/2374716","article-title":"Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis","volume":"2020","author":"Weeks","year":"2020","journal-title":"Obstet. Gynecol. Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa1814630","article-title":"Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer","volume":"380","author":"Khorana","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e1091","DOI":"10.1634\/theoncologist.2019-0676","article-title":"Fundamental Research in Oncology and Thrombosis 2 (FRONTLINE 2): A Follow-Up Survey","volume":"25","author":"Kakkar","year":"2020","journal-title":"Oncologist"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/jth.15607","article-title":"An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: Systematic review and meta-analysis","volume":"20","author":"Forgo","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e001152","DOI":"10.1161\/JAHA.114.001152","article-title":"External Validation of the Risk Assessment Model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for Medical Patients in a Tertiary Health System","volume":"3","author":"Rosenberg","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/rth2.12431","article-title":"Preventing venous thromboembolism in oncology practice: Use of risk assessment and anticoagulation prophylaxis","volume":"4","author":"Martin","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ygyno.2023.01.012","article-title":"Assessing the need for venous thromboembolism prophylaxis at the time of neoadjuvant chemotherapy for ovarian cancer: A literature review","volume":"170","author":"Moufarrij","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00345-019-02705-x","article-title":"Perioperative venous thromboembolism prophylaxis in prostate cancer surgery","volume":"38","author":"Klaassen","year":"2020","journal-title":"World J. Urol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/11\/1159\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:51:39Z","timestamp":1760107899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/14\/11\/1159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["diagnostics14111159"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics14111159","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]}}}